Navigation Links
Apollo Endosurgery Completes First-in-Human Cases With New OverStitch™ Endoscopic Suturing System
Date:10/28/2010

AUSTIN, Texas, Oct. 28 /PRNewswire/ -- Apollo Endosurgery, Inc. announced that their newly-launched OverStitch™ Endoscopic Suturing System has recently been employed in several, first-in-human cases.

OverStitch Endoscopic Suturing System is a unique device that mimics the way physicians deploy sutures by hand.  It provides full-thickness endoscopic suturing on a flexible platform, delivering surgical standard of care through the flexible endoscope.  

OverStitch was first used by Dr. Santiago Horgan at University of California, San Diego (UCSD) in a patient who had been suffering from multiple complications due to a gastric fistula, otherwise described as a "leak in the stomach". The OverStitch Endoscopic Suturing System was deployed endoscopically to facilitate the closure of the fistula.Dr. Christopher Gostout has since used the device at the Mayo Clinic (Rochester, MN) to repair an esophageal fistula.  The OverStitch Endoscopic Suturing System was utilized to place multiple sutures that effectively closed the fistula.  Dr. Gostout was ecstatic and said "the device worked flawlessly in the esophageal environment".  He further said "The device will address a wide variety of previously unmet needs for tissue apposition throughout the GI tract".

"The early reception of the OverStitch product has been exceptional; we are very excited to see our products providing clinicians the ability to offer less invasive endoscopic surgical treatment options" noted Lee Putman, Apollo Endosurgery Vice President of Sales & Marketing. "The OverStitch product provides Apollo an excellent opportunity to advance the potential of flexible surgery, while improving patient outcomes and lives".  Aiding this advancement, Apollo has created its Gemini (Gastrointestinal Endoscopic MINimally Invasive) Suturing Registry. The registry provides a tool whereby data can be collected and maintained from each case where the OverStitch product is employed.

About Apollo Endosurgery, Inc.Apollo Endosurgery, Inc. is dedicated to revolutionizing patient care through the development of flexible surgery, which is emerging from the convergence of laparoscopic surgery and therapeutic gastroenterology.  Flexible surgery minimizes the trauma of surgical access by taking advantage of natural orifices to deliver surgical tools to targeted areas.  All of Apollo's products are compatible with existing flexible endoscope platforms.  Apollo Endosurgery was co-founded with the Apollo Group, a unique collaboration of physicians from the Mayo Clinic, Johns Hopkins University, Medical University of South Carolina, the University of Texas Medical Branch and the Chinese University of Hong Kong.  The company is funded by PTV Sciences and H.I.G. Ventures.  

For more information, visit our website (www.apolloendo.com) or contact:Ted StephensDirector of MarketingApollo Endosurgery, Inc.512-328-9990 (o)513-312-9161 (m)
'/>"/>

SOURCE Apollo Endosurgery, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Apollo Endosurgery Completes First Clinical Case with Newly-Launched FlexShears™ Endoscopic Scissors
2. Boston Scientific Completes Acquisition of Asthmatx
3. Warner Chilcott Completes Acquisition of U.S. Rights to Enablex® Overactive Bladder Treatment for $400 Million in Cash
4. Highland Capital Management Announces 100% Ownership of American HomePatient, Completes Successful Public to Private Transition For Leading Provider of Home Respiratory Therapy
5. Incept BioSystems Completes First Human Clinical Trial of the SMART Start™ Embryo Culture System and Submits 510(k) Application to the FDA
6. InfraReDx Completes $21 Million Equity Financing
7. Ocular Therapeutix Completes Proof of Principle Study with Moxifloxacin-Loaded Punctum Plugs
8. Randomized Clinical Trial of OrbusNeichs Genous™ Bio-engineered R stent™ in China Completes Patient Enrollment
9. DiFUSION Technologies Completes Successful Antimicrobial Implant Animal Trial
10. IDEV Technologies Completes $46 Million Preferred Stock Financing With Piper Jaffray and Additional Strategic Investor
11. SAFC® Completes Expansion of High-Potency Fermentation Capabilities at Israel Site
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... 2016 Research and Markets has announced the ... their offering. ... R&D Drug Pipeline Database: 1-Year ... Drug Pipeline Database provides 24/7 online access to information about more ... and on investigational drug candidates in research & development. ...
(Date:12/2/2016)... , December 2, 2016 bioLytical Laboratories, un líder mundial ... el INSTI HIV Self Test , a los miembros de la Kenya ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) bioLytical fue ...
(Date:12/2/2016)...  LifeVac, the revolutionary device that has successfully rescued ... Training and Support Services (ERTSS) training programs. ... part of the ERTSS mission to save lives," said ... "Having an established network of expert trainers demonstrating how ... our efforts to spread LifeVac,s message that choking deaths ...
Breaking Medicine Technology:
(Date:12/4/2016)... ... December 03, 2016 , ... While James Earl Jones is known for myriad ... a show called "Front Page". One of the forthcoming episodes examines mammogram techniques; a ... plummeted in large part due to early detection. Like any other disease, treatments have ...
(Date:12/4/2016)... CA (PRWEB) , ... December 04, 2016 , ... ... without undergoing major cosmetic surgery can now take advantage of a cosmetic procedure ... advanced skin rejuvenation treatment that reduces the appearance of age spots, fine ...
(Date:12/2/2016)... ... 02, 2016 , ... Lori G. Cohen and Sara K. ... at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference , ... of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & Health ...
(Date:12/2/2016)... ... December 02, 2016 , ... More than 100 ... are expected to attend the UNCF Dothan-Wiregrass Mayor’s Luncheon Dec. 9, 2016. This ... area students and operating support to UNCF-member institutions, including Miles College, Oakwood University, ...
(Date:12/2/2016)... , ... December 02, 2016 , ... The annual time ... Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare beneficiaries who are ... or prescription drug plan (Part D) need to make changes during this period order ...
Breaking Medicine News(10 mins):